News & Perspective

May 01, 2013

May 01, 2013

WHO report: Global guidance on dual-use research needed

(CIDRAP News) – Participants in a World Health Organization (WHO) meeting held in February agreed that a binding global agreement to govern potentially dangerous life-sciences research is unlikely, but global guidance on the thorny issue could help nations figure out their own policies, according to a WHO report of the meeting.

May 01, 2013

US labs progress with H7N9 studies as CDC urges readiness

(CIDRAP News) – As labs in the United States study how the H7N9 virus behaves in humans and animals, state and local health officials should dust off their pandemic preparedness plans in case the virus becomes a bigger threat, the US Centers for Disease Control and Prevention (CDC) said today.

Apr 09, 2013

Apr 09, 2013

CDC activates emergency center over H7N9

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) activated its Emergency Operations Center (EOC) in Atlanta yesterday to support the response to the H7N9 influenza outbreak in China, CDC officials said in an e-mailed statement today.

Apr 08, 2013

Apr 08, 2013

CDC waiting for H7N9 sample to speed test kits

(CIDRAP News) – A human isolate of the novel H7N9 influenza virus from China—needed for the development of diagnostic test kits and related efforts—is expected to arrive at the Centers for Disease Control and Prevention (CDC) within 2 days, a CDC official said today.

Apr 03, 2013

Apr 03, 2013

NBSB unveils situational awareness, SNS recommendations

(CIDRAP News) – The National Biodefense Science Board (NBSB) today forwarded two sets of recommendations to federal departments that oversee emergency preparedness, one focused on enhancing situational awareness in health emergencies and the other on improving the nation's Strategic National Stockpile (SNS) by 2020.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»